Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Hervé Bachelez, MD, PhD
Department of Dermatology, Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris
Paris, France
IPC Board Member

Professor Bachelez is professor at the Department of Dermatology of the Assistance Publique-Hôpitaux de Paris Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in Immunology in 1999. Professor Bachelez’s clinical and research activities focus on inflammatory skin diseases, mainly psoriasis and psoriasis-related diseases, but also hidradenitis suppurativa, lichen planus among others. He is conducting his basic and translational research at the Institut National de la Santé et de la Recherche Médicale (INSERM U1163), in the Laboratory of Genetics of Skin Diseases at the Imagine Institute for Human Genetic Diseases in Necker Hospital, Paris. His areas of scientific research include immunogenetics and molecular mechanisms of the aforementioned immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is the past president of the French society for Dermatological Research and of the Group for Research on Psoriasis of the French Society for Dermatology. Internationally, he is a board member of the International Psoriasis Council, and is currently serving as General Secretary-Treasurer and President-Elect of the European Society for Dermatological Research (ESDR). Professor Bachelez has published more than 255 manuscripts in peer-reviews journals, including the New England Journal of Medicine, Journal of Clinical Investigation, the Lancet, and Arthritis and Rheumatism as leading author.

Last Updated: May 04, 2021



Liv Eidsmo, MD, PhD
LEO Foundation Skin Immunology Research Center
Copenhagen, Denmark

Liv Eidsmo is Professor of Translational Skin Immunology and was recruited as Executive Director of the LEO Foundation Skin Immunology Research Center at the University of Copenhagen in 2021. Professor Eidsmo’s research focuses on how T cells residing in the skin drive local recurrence of diseases such as psoriasis and vitiligo.

Professor Eidsmo graduated medical school in 1999 and defended her PhD in Immunobiology at Karolinska Institutet in 2006. Following a postdoc in Frank Carbone's laboratory at Melbourne University in Australia from 2007-09, she returned to Sweden to start up her own lab at the Center for Molecular Medicine (CMM) at Karolinska Institutet in parallel to clinical training in dermatology at Karolinska University Hospital. Professor Eidsmo has a wide international network and is regularly invited as a speaker at international conferences. She has received multiple academic honors and awards, including the Ellis and Ivar Janzon's Prize, The Swedish Society of Medicine (2017), Marcus and Marianne Wallenberg Clinical Research Fellow (2016) and the Ragnar Söderberg Fellowship (2014).

Last Updated: Sep 22, 2021

University of Leeds
Leeds, England, United Kingdom

Prof Emery trained at Cambridge, Guy’s and Brompton. Since 1995 he has been Versus Arthritis UK (formerly ARC) Professor of Rheumatology in Leeds, Director of the Leeds NIHR Biomedical Research Centre 2009-present. Prof Emery was President of EULAR 2009-2011. He was inaugural chair of FOREUM Executive. He is an ACR Master. He has served on the editorial boards of all the major rheumatology journals.  He has been an NIHR Senior Investigator since 2008. In 2020 he received the Meritorious Service Award from EULAR and became Fellow of the Learned Society of Wales in 2021.

Professor Emery’s research interests centre around the immunopathogenesis and immunotherapy of rheumatoid arthritis, SpA, psoriatic disease and connective tissue diseases.  He has a special interest in the factors leading to persistent inflammation.  He is currently focusing on the prevention of autoimmune diseases with national programmes identifying patients in the pre-clinical phase. He has published >1200 peer-reviewed articles in this area and has an h index of >140.

Last Updated: Sep 14, 2021

Luigi Naldi, MD
Centro Studi GISED
Bergamo, Italy

Luigi Naldi took a diploma in Classical Studies and a Degree in Industrial Design at Scuola Politecnica di Design in Milan before moving to Medicine. He graduated as a medical doctor at the University of Pavia in 1981. From 1984 to 1986 he was a junior investigator at the Laboratory of Clinical Pharmacology of the Mario Negri Institute in Milan. In 1988 he moved to the clinical arena (Dermatology) at the Department of Dermatology of the University of Milan, Bergamo General Hospital. He qualified as a full professor of Dermatology in 2013. In 2017, he started a new clinical position as Director of the Department of Dermatology, at the General Hospital of Vicenza. He always considered the clinical setting as the natural laboratory for clinical research. Since 1986 he is coordinating a collaborative research group in Italy, the Italian Group for Epidemiologic Research in Dermatology (GISED). He is a co-founder of the European Dermatoepidemiology Network (EDEN). In 2003, he established a research center at the Bergamo General Hospital, Centro Studi GISED, with the aim of promoting integrated clinical research programs in Dermatology.

Last Updated: Sep 07, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.